2023 in review

Trichollective
A woman with cropped platinum hair swept up and back, eyes closed, in soft side light
2023 · Year in reviewLooking back at 2023

Trichozette

Four years in review

2023 in review

The year the rules started to move.

Contents

A retrospective look at 2023 across the cosmetic, clinical and medical fields: new medicines for alopecia areata, a licensing consultation for cosmetic procedures in England, and a quality mark for a trichology register.

  1. 01LetterLooking back at 2023
  2. 02The yearThe biggest shifts of 2023
  3. 03Three perspectivesOne year, three chairs
  4. 04Timeline2023 at a glance
  5. 05Photograph2023 asked every discipline the same question: what is ours to do, and when do we pass the work on?
  6. 06PracticeWhat 2023 means for practice
  7. 07Test yourselfHow well do you know 2023?

From the editors

Looking back at 2023

This edition looks back at 2023. Trichozette did not exist then, and neither did Trichollective, whose story begins at Whittlebury Hall in January 2026. These are not back issues. They are part of a retrospective series, Four years in review, in which we return to each of the last four years and ask a plain question: what actually changed for the people who look after hair and scalps?

For 2023 the answer is more than you might remember. A second oral medicine for severe alopecia areata was approved in the United States, then in Europe and the UK, while the health technology bodies in England and Scotland declined to fund an earlier one. The government in England opened a consultation on licensing non-surgical cosmetic procedures. Advertising regulators turned their attention to hair transplant clinics. And in December, the Institute of Trichologists' register was accredited by the Professional Standards Authority.

None of these stories stayed in one lane. A licensing proposal written for injectables named scalp treatments too. A medicine approved for dermatologists changed what clients asked their stylists. A register accreditation changed how trichologists could describe themselves. That is why this edition gives each change three readings, one from each discipline.

Every factual claim in this volume comes from a source we have listed at the end. Where we could not verify something, we left it out. Where a story continued into later years, we say so and stop at the edge of 2023. The three field editions that follow go deeper into the cosmetic, clinical and medical detail.

The Trichollective editorial team

Profile of a Black woman with a long, sleek braided ponytail against a plain studio backdrop

The year

The biggest shifts of 2023

New medicines, new rules and a new mark of assurance. How 2023 changed the ground under all three disciplines.

Photograph Jessica Felicio / Unsplash

Words by the Trichollective editorial team

Some years are remembered for a single headline. 2023 was different: several slow-moving stories reached a turning point at roughly the same time, and each of them touched more than one discipline. Taken together they explain a good deal about how hair and scalp care looks today.

Medicine: a second option, and a question of cost

On 23 June 2023 the US Food and Drug Administration approved ritlecitinib for severe alopecia areata in people aged 12 and over, the first treatment approved there for adolescents with the condition. The European Commission followed in September, and the MHRA authorised it for the UK in the autumn. Meanwhile, the funding bodies took a harder look at baricitinib, an earlier medicine in the same class. The Scottish Medicines Consortium did not accept it for severe alopecia areata in August, and NICE did not recommend it in October, in both cases because the cost-effectiveness case was uncertain.

In April the MHRA had also issued new safety measures for several JAK inhibitors used in chronic inflammatory conditions. The lesson for everyone was that these medicines are serious, specialist treatments, and not a quick fix to be promised in a salon.

Cosmetic practice: licensing on the horizon

On 2 September the Department of Health and Social Care opened a consultation on a licensing scheme for non-surgical cosmetic procedures in England, to be run by local authorities. It proposed sorting procedures into green, amber and red categories by risk, and a minimum client age of 18. Microneedling and micropigmentation appeared in the green list, platelet-rich plasma therapy in amber and hair restoration surgery in red.

“

Several slow-moving stories reached a turning point at roughly the same time.

Trichology: a mark of assurance

On 14 December the Professional Standards Authority accredited the register held by the Institute of Trichologists, with conditions. Accreditation is voluntary assurance of a register's standards, not statutory regulation: trichology is still not statutorily regulated in the UK or Ireland. But it gave the public a clearer way to check a practitioner's standing.

  • Medical: a second oral option for severe alopecia areata, alongside hard questions about value and safety.
  • Cosmetic: a proposed licensing scheme in England that named scalp treatments as well as injectables.
  • Clinical: accreditation of a trichology register, and a busy year of research on scarring and traction hair loss.

The pages that follow take each story in turn, starting with how the three disciplines saw the same year from their own chairs.

Sources

Every fact in this edition, and where it came from.

  1. 1.Pfizer: FDA approves LITFULO (ritlecitinib) for adults and adolescents with severe alopecia areata, 23 June 2023
  2. 2.Business Wire: European Commission approves LITFULO for adolescents and adults with severe alopecia areata, September 2023
  3. 3.European Pharmaceutical Review: MHRA authorises alopecia treatment, 3 November 2023
  4. 4.Scottish Medicines Consortium: August 2023 decisions news release
  5. 5.NICE TA926: Baricitinib for treating severe alopecia areata (October 2023)
  6. 6.Sun Pharma: US FDA filing acceptance of the new drug application for deuruxolitinib, October 2023
  7. 7.MHRA Drug Safety Update: Janus kinase (JAK) inhibitors, new measures to reduce risks, 26 April 2023
  8. 8.DHSC: The licensing of non-surgical cosmetic procedures in England, consultation (2 September to 28 October 2023)
  9. 9.ASA Ruling on GET DHI Hair Clinic, 11 October 2023
  10. 10.DWF: ASA rulings round-up, 11 October 2023
  11. 11.European Commission: Regulation (EU) 2023/2055, restriction of microplastics intentionally added to products
  12. 12.Professional Standards Authority: Quality Mark awarded to the Institute of Trichologists, 14 December 2023
  13. 13.World Trichology Conference 2023, Royal Society of Medicine, London (Institute of Trichologists and International Association of Trichologists)
  14. 14.Archives of Dermatological Research (2023): Frontal fibrosing alopecia and personal care product use, a systematic review and meta-analysis
  15. 15.Clinical and Experimental Dermatology (2023): Traction alopecia, presentation, management and outcomes in a diverse urban population
  16. 16.British Beauty Council: Value of Beauty 2023, 26 April 2023

Free with an account

There are 5 more features in this edition.

Create a free Trichollective account to read every edition of Trichozette in full, including the archive from 2023 to 2026, with a new edition each month.

Already have an account? Sign in

Still to read

  1. 03Three perspectivesOne year, three chairs
  2. 04Timeline2023 at a glance
  3. 05Photograph2023 asked every discipline the same question: what is ours to do, and when do we pass the work on?
  4. 06PracticeWhat 2023 means for practice
  5. 07Test yourselfHow well do you know 2023?

Free for every professional

Create a free account and read every edition in full.

Free, with a directory listing that stays free for as long as you like.

  • Read every edition of Trichozette in full, including the archive from 2023 to 2026
  • A basic directory listing that stays free for as long as you like: name, discipline, town and specialism
  • Your full profile free for 90 days: photo, services, website and enquiries sent straight to you

Membership

Join as a member and keep the conversation going between events.

From £6 (€7) a month at the founding price, which you keep while you stay.

  • Learn at a live masterclass and case round each month, with recordings to watch between clients
  • Ask questions in every open space, meet your country chapter and message any member directly
  • Pay member prices on courses and conferences
  • Save with member perks from partner brands

For clinics, salons and brands

List your clinic or brand where professionals look for referrals.

Start with a free directory listing for 90 days, or take a full business page from £99 (€115) a month.

  • Be found in the directory with a full business page in your own colours, with your story, products and services, and up to 8 photos
  • Give five of your team Professional membership
  • Advertise roles on the jobs board to trained hair and scalp professionals

Next · 2023 · Cosmetic

Cosmetic, 2023

Licences, labels and honest adverts.